DXS International (STU:7EE) Valuation Rank


STU:7EE DXS International PLC STU:7EE
39 GF Score
Price €0.01
GF Value €0.02
! 2 Warning Signs
View Full Analysis

What is DXS International Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

DXS International Valuation Rank Related Terms

STU:7EE
39GF Score
DXS International PLC STU:7EE
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DXS International (STU:7EE) Overvalued in 2026?

Based on GuruFocus' analysis, DXS International stock appears to be undervalued. The current stock price of €0.01 is trading 45% below its estimated GF Value™ of €0.02.

Key valuation signals for STU:7EE:

  • Valuation Rank:
  • GF Value™: €0.02 vs. price of €0.01 (45% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the STU:7EE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DXS International Business Description

Other Exchanges DXSP:UK
Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
39GF Score

Get the complete analysis for STU:7EE

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price
€0.02
GF Value